Illinois Cannabis Sales Drop 14% From December

Cannabis sales in Illinois for the month of January grew 32% over last year but fell sequentially by 14% from December. Last Friday, the Illinois Department of Professional and Financial Regulation released cannabis monthly sales figures and then on Monday, the Illinois Department of Public Health (IDPH) released its latest statistics for the medical cannabis program.

So far in 2022, 2,645,046 items were sold in January. In-state residents spent over $81 million while out-of-state residents spent roughly $35 million for a total of $117 million. In January 2021, sales were $88.8 million in total, while December sales topped $137 million. The state saw a slight growth in sales between 2020’s December and 2021’s January so there was no precedent for this drop.

Medical Sales

The state reported that retail sales of medical cannabis in January were $29,686,123.47 including $14,083,522.33 in dry flower sales and $15,602,601.14 in concentrates/infused-products. Licensed medical cannabis dispensaries served 65,041 unique patients, who purchased 1,130,332 grams of dry cannabis.

Illinois said it has approved applications for 195,235 qualifying patients (including 911 persons under 18 years of age), since it began accepting applications for the Medical Cannabis Registry Program on September 2, 2014. Current total number of active patients in the MCPP program as of February 7, 2022 are 134,834.

Overall Medical Cannabis Patient Program Data, as of January 31, 2021:

Number of Licensed Medical Cannabis Dispensaries — 55
2022 Total Retail Sales by Licensed Medical Cannabis Dispensaries — $29,686,123.47
Total Retail Sales since November 2015 by Licensed Medical Cannabis Dispensaries — $1,314,861,555.14
2022 Total Wholesale Sales by Cultivation Centers — $26,321,615.58
Total Wholesale Sales since November 2015 by Cultivation Centers — $1,766,817,705.62

The Opioid Alternative Pilot Program (OAPP) was launched by the Illinois Department of Public Health (IDPH) on January 31, 2019. The OAPP provides access to medical cannabis for individuals who have or could receive a prescription for opioids as certified by a health care professional licensed in Illinois.

Opioid Alternative Pilot Program data, as of February 7, 2022:

OAPP patients registered — 523
OAPP patients awaiting health care professional certification — 344
Number of Health Care Professionals registered with OAPP/MCPP — 3198

Debra Borchardt

Debra Borchardt is the Co-Founder, and Executive Editor of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Master's degree in Business Journalism from New York University.


Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 2 hours

Nevada Cannabis Sales Drop For Fiscal 2022

@GreenMarketRpt – 3 hours

Croptober Not Feeling So Celebratory

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.